What are Insulin combination therapy drugs?

Insulin combination therapy drugs are pharmacologic agents that share a common mechanism (typically targeting Insulin receptor). 6 are currently marketed, with 2 more in clinical development.

What are the marketed Insulin combination therapy drugs?

Marketed Insulin combination therapy drugs include Humulin N plus Humulin R, NPH/Reg, Lispro Mixture Therapy, NPH and regular insulin, Premixed insulin, Lispro Mid Mix.

Insulin combination therapy

6 marketed 2 in Phase 3

This page covers all Insulin combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (6)

Humulin N plus Humulin R · Université NAZI BONI · Diabetes
This combination of intermediate-acting (NPH) and rapid-acting insulin provides basal and prandial glucose control by facilitating cellular glucose uptake and metabolism.
NPH/Reg · Tehran University of Medical Sciences · Diabetes
NPH/Reg is a combination insulin therapy that provides both intermediate-acting (NPH) and rapid-acting (Regular) insulin to control blood glucose levels.
Lispro Mixture Therapy · Eli Lilly and Company · Diabetes
Lispro Mixture is a combination of rapid-acting insulin lispro and intermediate-acting insulin lispro protamine suspension that mimics physiologic insulin secretion by providing both mealtime and basal insulin coverage.
NPH and regular insulin · Riverside University Health System Medical Center · Diabetes
NPH and regular insulin work together to replace or supplement the body's natural insulin, allowing cells to take up glucose and lowering blood sugar levels.
Premixed insulin · Peking University People's Hospital · Diabetes
Premixed insulin combines rapid-acting and intermediate-acting insulin to provide both immediate and sustained blood glucose control.
Lispro Mid Mix · Eli Lilly and Company · Diabetes
Lispro Mid Mix is a fixed-ratio combination of rapid-acting insulin lispro and intermediate-acting insulin isophane that mimics the body's natural insulin secretion pattern by providing both immediate and sustained glucose control.

Phase 3 pipeline (2)

Insulin Glargine - Insulin Aspart · Hospital Universitario San Ignacio · Diabetes
This combination of long-acting basal insulin (glargine) and rapid-acting mealtime insulin (aspart) works together to regulate blood glucose by replacing the body's natural insulin secretion pattern.
Humalog Mix 50 · Eli Lilly and Company · Diabetes
Humalog Mix 50 is a combination insulin therapy that provides both rapid-acting and intermediate-acting insulin to control blood glucose levels in diabetes.